InsidersTradesSigma
Follow the Pharmanutra PR - Pharmanutra - PHN - Cetilar Side by Side With Fernando Alonso stock price and the full management transaction log of the company, a publicly traded company based in Italy. Shares trade on the IT market, under the authority of Consob. Operating in the Health Care sector, Pharmanutra PR - Pharmanutra - PHN - Cetilar Side by Side With Fernando Alonso has recorded 1 public disclosures. Market capitalisation: €799.5m. The latest transaction was filed on 26 May 2023 (Other). All data is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,563 of 29,064 companies
61.7
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.8x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 May 2023
关于 Pharmanutra PR - Pharmanutra - PHN - Cetilar Side by Side With Fernando Alonso
Pharmanutra 是一家专注于健康和制药领域的公司，以其创新产品而闻名。该公司在 XMIL 市场上市，最近与费尔南多·阿隆索合作推广其 Cetilar 品牌。